Skip to main content
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
73.64
-1.12 (-1.50%)
At close: Dec 5, 2025, 4:00 PM EST
74.99
+1.35 (1.83%)
After-hours: Dec 5, 2025, 7:22 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Transformative Medicines
221.90M
Log In
Log In
Log In
Log In
Upgrade
Transformative Medicines Growth
2285.27%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
EMEA
132.03M
Log In
Log In
Log In
Log In
Upgrade
APAC
76.56M
Log In
Log In
Log In
Log In
Upgrade
North America
13.31M
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade
China Growth
-
Log In
Log In
Log In
Log In
Upgrade
Foreign
-
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
-
Log In
Log In
Log In
Log In
Upgrade
Switzerland
-
Log In
Log In
Log In
Log In
Upgrade